-
1دورية أكاديمية
المؤلفون: Larkin, J, Del Vecchio, M, Mandala, M, Gogas, H, Arance, AM, Dalle, S, Cowey, CL, Schenker, M, Grob, J-J, Chiarion-Sileni, V, Marquez-Rodas, I, Butler, MO, Di Giacomo, AM, Middleton, MR, Lutzky, J, de la Cruz-Merino, L, Arenberger, P, Atkinson, V, Hill, AG, Fecher, LA, Millward, M, Nathan, PD, Khushalani, NI, Queirolo, P, Ritchings, C, Lobo, M, Askelson, M, Tang, H, Dolfi, S, Ascierto, PA, Weber, J
المساهمون: Larkin, James
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; CCR-22-3145 -; application/pdf
العلاقة: 725906; Clinical Cancer Research, 2023, pp. CCR-22-3145 -; https://repository.icr.ac.uk/handle/internal/5881Test
الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-3145Test
https://repository.icr.ac.uk/handle/internal/5881Test -
2دورية أكاديمية
المؤلفون: Buckley, HL, Collinson, FJ, Ainsworth, G, Poad, H, Flanagan, L, Katona, E, Howard, HC, Murden, G, Banks, RE, Brown, J, Velikova, G, Waddell, T, Fife, K, Nathan, PD, Larkin, J, Powles, T, Brown, SR, Vasudev, NS
المساهمون: Larkin, James
مصطلحات موضوعية: Humans, Carcinoma, Renal Cell, Neoplasm Metastasis, Antineoplastic Combined Chemotherapy Protocols, Disease-Free Survival, Treatment Outcome, Drug Administration Schedule, Quality of Life, Adult, Aged, Middle Aged, Female, Male, CTLA-4 Antigen, Programmed Cell Death 1 Receptor, Ipilimumab, Nivolumab
وصف الملف: Electronic; ?; application/pdf
العلاقة: BMC cancer, 2019, 19 (1), pp. 1102 - ?; https://repository.icr.ac.uk/handle/internal/4145Test
الإتاحة: https://doi.org/10.1186/s12885-019-6273-1Test
https://repository.icr.ac.uk/handle/internal/4145Test -
3دورية أكاديمية
المؤلفون: Buckley, HL, Collinson, FJ, Ainsworth, G, Poad, H, Flanagan, L, Katona, E, Howard, HC, Murden, G, Banks, RE, Brown, J, Velikova, G, Waddell, T, Fife, K, Nathan, PD, Larkin, J, Powles, T, Brown, SR, Vasudev, NS
وصف الملف: text
العلاقة: https://eprints.whiterose.ac.uk/152386/8/s12885-019-6273-1.pdfTest; Buckley, HL orcid.org/0000-0002-9829-5817 , Collinson, FJ, Ainsworth, G et al. (15 more authors) (2019) PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. BMC Cancer, 19. ARTN: 1102. ISSN 1471-2407
-
4دورية أكاديمية
المؤلفون: Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ, Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA, Middleton, MR, AVAST-M Investigators
وصف الملف: application/pdf
العلاقة: https://openaccess.sgul.ac.uk/id/eprint/110092/1/AVAST-M%20trial,%20Corrie%20et%20al.pdfTest; Corrie, PG; Marshall, A; Nathan, PD; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, CG; Marples, M; Danson, SJ; et al. Corrie, PG; Marshall, A; Nathan, PD; Lorigan, P; Gore, M; Tahir, S; Faust, G; Kelly, CG; Marples, M; Danson, SJ; Marshall, E; Houston, SJ; Board, RE; Waterston, AM; Nobes, JP; Harries, M; Kumar, S; Goodman, A; Dalgleish, A; Martin-Clavijo, A; Westwell, S; Casasola, R; Chao, D; Maraveyas, A; Patel, PM; Ottensmeier, CH; Farrugia, D; Humphreys, A; Eccles, B; Young, G; Barker, EO; Harman, C; Weiss, M; Myers, KA; Chhabra, A; Rodwell, SH; Dunn, JA; Middleton, MR; AVAST-M Investigators (2018) Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial. Ann Oncol, 29 (8). pp. 1843-1852. ISSN 1569-8041 https://doi.org/10.1093/annonc/mdy229Test SGUL Authors: Dalgleish, Angus George
الإتاحة: https://doi.org/10.1093/annonc/mdy229Test
https://openaccess.sgul.ac.uk/id/eprint/110092Test/
https://openaccess.sgul.ac.uk/id/eprint/110092/1/AVAST-M%20trial,%20Corrie%20et%20al.pdfTest -
5مؤتمر
المؤلفون: Vasudev, NS, Ainsworth, G, Brown, S, Pickering, L, Waddell, TS, Fife, K, Griffiths, R, Sharma, A, Katona, E, Howard, H, Velikova, G, Maraveyas, A, Brown, JE, Venugopal, B, Patel, P, Jain, A, Symeonides, S, Nathan, PD, Collinson, F, Powles, TB
العلاقة: Vasudev, NS orcid.org/0000-0001-8470-7481 , Ainsworth, G, Brown, S orcid.org/0000-0002-7975-7537 et al. (17 more authors) (2021) LBA29 Nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced renal cell carcinoma: A randomized phase II trial (PRISM). In: ESMO Congress 2021, 16-21 Sep 2021, Virtual.
-
6دورية أكاديمية
المؤلفون: Dummer R, Lebbé C, Atkinson V, MANDALA' M, Nathan PD, Arance A, Richtig E, Yamazaki N, Robert C, Schadendorf D, Tawbi HA, Ascierto PA, Ribas A, Flaherty KT, Pakhle N, Campbell CD, Gusenleitner D, Masood A, Brase JC, Gasal E, Long GV
المساهمون: Dummer, R, Lebbé, C, Atkinson, V, Mandala', M, Nathan, Pd, Arance, A, Richtig, E, Yamazaki, N, Robert, C, Schadendorf, D, Tawbi, Ha, Ascierto, Pa, Ribas, A, Flaherty, Kt, Pakhle, N, Campbell, Cd, Gusenleitner, D, Masood, A, Brase, Jc, Gasal, E, Long, Gv
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33020648; info:eu-repo/semantics/altIdentifier/wos/WOS:000575801100006; volume:26; issue:10; firstpage:1557; lastpage:1563; journal:NATURE MEDICINE; http://hdl.handle.net/11391/1480904Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85092093929
-
7دورية أكاديمية
المؤلفون: Robert C, Grob JJ, Stroyakovskiy D, Karaszewska B, Hauschild A, Levchenko E, Chiarion Sileni V, Schachter J, Garbe C, Bondarenko I, Gogas H, MANDALA' M, Haanen JBAG, Lebbé C, Mackiewicz A, Rutkowski P, Nathan PD, Ribas A, Davies MA, Flaherty KT, Burgess P, Tan M, Gasal E, Voi M, Schadendorf D, Long GV
المساهمون: Robert, C, Grob, Jj, Stroyakovskiy, D, Karaszewska, B, Hauschild, A, Levchenko, E, Chiarion Sileni, V, Schachter, J, Garbe, C, Bondarenko, I, Gogas, H, Mandala', M, Haanen, Jbag, Lebbé, C, Mackiewicz, A, Rutkowski, P, Nathan, Pd, Ribas, A, Davies, Ma, Flaherty, Kt, Burgess, P, Tan, M, Gasal, E, Voi, M, Schadendorf, D, Long, Gv
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000481462800008; journal:NEW ENGLAND JOURNAL OF MEDICINE; http://hdl.handle.net/11391/1480869Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85069667308
-
8
المؤلفون: Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ, Marshall, E, Houston, SJ, Board, RE, Waterston, AM, Nobes, JP, Harries, M, Kumar, S, Goodman, A, Dalgleish, A, Martin-Clavijo, A, Westwell, S, Casasola, R, Chao, D, Maraveyas, A, Patel, PM, Ottensmeier, CH, Farrugia, D, Humphreys, A, Eccles, B, Young, G, Barker, EO, Harman, C, Weiss, M, Myers, KA, Chhabra, A, Rodwell, SH, Dunn, JA, Middleton, MR, Investigators, AVAST-M
المصدر: ANNALS OF ONCOLOGY
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::8b659aae2c5afd3627b833b57ae597d8Test
-
9دورية أكاديمية
المؤلفون: Corrie PG, Marshall A, Nathan PD, Lorigan P, Gore M, Tahir S, Faust G, Kelly CG, Marples M, Danson SJ, Marshall E, Houston SJ, Board RE, Waterston AM, Nobes JP, Harries M, Kumar S, Goodman A, Dalgleish A, Martin-Clavijo A, Westwell S, Casasola R, Chao D, Maraveyas A, Patel PM, Ottensmeier CH, Farrugia D, Humphreys A, Eccles B, Young G, Barker EO, Harman C, Weiss M, Myers KA, Chhabra A, Rodwell SH, Dunn JA, Middleton MR
المصدر: Annals of Oncology, 2018
وصف الملف: application/pdf
-
10دورية أكاديمية
المؤلفون: Bridgeman, VL, Wan, E, Foo, S, Nathan, MR, Welti, JC, Frentzas, S, Vermeulen, PB, Preece, N, Springer, CJ, Powles, T, Nathan, PD, Larkin, J, Gore, M, Vasudev, NS, Reynolds, AR
المساهمون: Bridgeman, Victoria, Foo, Shane, Nathan, Mark, Preece, Natasha, Springer, Caroline, Reynolds, Andrew
مصطلحات موضوعية: Cell Line, Tumor, Endothelial Cells, Animals, Humans, Carcinoma, Renal Cell, Kidney Neoplasms, Disease Models, Animal, Neovascularization, Pathologic, Pyridones, Pyrimidinones, Pyrroles, Indoles, Angiogenesis Inhibitors, Protein Kinase Inhibitors, Drug Evaluation, Preclinical, Xenograft Model Antitumor Assays, MAP Kinase Signaling System, Drug Synergism, Drug Resistance, Neoplasm, Female, Von Hippel-Lindau Tumor Suppressor Protein, Sunitinib
وصف الملف: Print-Electronic; 183; application/pdf
العلاقة: Molecular cancer therapeutics, 2016, 15 (1), pp. 172 - 183; https://repository.icr.ac.uk/handle/internal/1997Test
الإتاحة: https://doi.org/10.1158/1535-7163.mct-15-0170Test
https://repository.icr.ac.uk/handle/internal/1997Test